Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck/Medco merger

Executive Summary

Merck's proposed acquisition of Medco Containment Services clears the final regulatory hurdle with the Federal Trade Commission's Nov. 5 notification that FTC has terminated its investigation into the antitrust aspects of the merger. Merck and Medco were in the process of collecting information that was requested by FTC in September when they were notified of the early termination of the Hart-Scott-Rodino waiting period. Medco stockholders will consider and vote on the merger and the formal merger agreement at a Nov. 18 special meeting.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel